FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178643921> ?p ?o ?g. }

• W3178643921 endingPage "e273" @default.
• W3178643921 startingPage "e273" @default.
• W3178643921 abstract "Objectives: Non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) is a common problem associated with obesity and type 2 diabetes mellitus (T2DM). There have been anecdotal reports of the efficacy of sodium-glucose cotransporter 2 inhibitors (SGLT2Is) in improving liver function parameters in those with concomitant T2DM and NAFLD/NASH. We sought to systematically evaluate the evidence of SGLT2Is in improving liver function parameters in T2DM patients with NAFLD, considering the risks of random error based on trial sequential analysis (TSA). We also performed a meta-analysis based on a random-effects model. Methods: A systematic literature search was performed using the Medline, Cochrane, and Embase databases from inception to 20 October 2018. Primary outcome for meta-analyses was the changes in hepatic enzyme levels (alanine transaminase, aspartate transaminase, and gamma-glutamyl transpeptidase). We also performed a meta-analysis on changes in insulin resistance, glycemic, and lipid parameters using SGLT2Is as a secondary objective. Results: Eight eligible randomized controlled studies were eligible for analysis. Meta-analysis showed the efficacy of two SLT2Is, dapagliflozin, and canagliflozin in reducing these enzymes level. TSA showed that canagliflozin significantly reduced the gamma-glutamyl transpeptidase level by weighted mean difference (-5.474, 95% confidence interval (CI): -6.289–-4.659) compared to others comparators, and the evidence is conclusive. Dapagliflozin also had a statistically significant reduction in glycated hemoglobin, which is a parameter of glycemic control and homeostatic model assessment for insulin sensitivity (HOMA-IR), which is a parameter of insulin sensitivity by a weight mean difference, -0.732 (95% CI: -1.087–-0.378) and -0.804 (95% CI: -1.336–0.272), respectively. Conclusions: This study indicated that canagliflozin effectively improves liver function parameters among patients with diabetes, while dapagliflozin is more effective in improving glycemic indices and insulin sensitivity." @default.
• W3178643921 created "2021-07-19" @default.
• W3178643921 creator A5008857932 @default.
• W3178643921 creator A5015645779 @default.
• W3178643921 creator A5021457387 @default.
• W3178643921 creator A5027464081 @default.
• W3178643921 creator A5033768100 @default.
• W3178643921 creator A5074382097 @default.
• W3178643921 creator A5076594577 @default.
• W3178643921 date "2021-05-15" @default.
• W3178643921 modified "2023-10-16" @default.
• W3178643921 title "Effect of SGLT-2 Inhibitors on Non-alcoholic Fatty Liver Disease among Patients with Type 2 Diabetes Mellitus: Systematic Review with Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials" @default.
• W3178643921 cites W1793828893 @default.
• W3178643921 cites W1946550634 @default.
• W3178643921 cites W1978128204 @default.
• W3178643921 cites W1995006519 @default.
• W3178643921 cites W2010149513 @default.
• W3178643921 cites W2026049223 @default.
• W3178643921 cites W2029811522 @default.
• W3178643921 cites W2045911846 @default.
• W3178643921 cites W2071045738 @default.
• W3178643921 cites W2077666699 @default.
• W3178643921 cites W2094469086 @default.
• W3178643921 cites W2135400982 @default.
• W3178643921 cites W2153997209 @default.
• W3178643921 cites W2161374186 @default.
• W3178643921 cites W2161596956 @default.
• W3178643921 cites W2165010366 @default.
• W3178643921 cites W2176459589 @default.
• W3178643921 cites W2275659322 @default.
• W3178643921 cites W2284028653 @default.
• W3178643921 cites W2551481457 @default.
• W3178643921 cites W2573090827 @default.
• W3178643921 cites W2576291926 @default.
• W3178643921 cites W2589458078 @default.
• W3178643921 cites W2591859981 @default.
• W3178643921 cites W2732773839 @default.
• W3178643921 cites W2737083386 @default.
• W3178643921 cites W2742155329 @default.
• W3178643921 cites W2761135733 @default.
• W3178643921 cites W2805050451 @default.
• W3178643921 cites W2808615577 @default.
• W3178643921 cites W2810354499 @default.
• W3178643921 cites W2810729752 @default.
• W3178643921 cites W2884837248 @default.
• W3178643921 cites W2890673765 @default.
• W3178643921 cites W2917128826 @default.
• W3178643921 cites W2982602066 @default.
• W3178643921 cites W2991470000 @default.
• W3178643921 cites W38634559 @default.
• W3178643921 cites W4231845294 @default.
• W3178643921 doi "https://doi.org/10.5001/omj.2021.62" @default.
• W3178643921 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8246653" @default.
• W3178643921 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34239714" @default.
• W3178643921 hasPublicationYear "2021" @default.
• W3178643921 type Work @default.
• W3178643921 sameAs 3178643921 @default.
• W3178643921 citedByCount "9" @default.
• W3178643921 countsByYear W31786439212021 @default.
• W3178643921 countsByYear W31786439212022 @default.
• W3178643921 countsByYear W31786439212023 @default.
• W3178643921 crossrefType "journal-article" @default.
• W3178643921 hasAuthorship W3178643921A5008857932 @default.
• W3178643921 hasAuthorship W3178643921A5015645779 @default.
• W3178643921 hasAuthorship W3178643921A5021457387 @default.
• W3178643921 hasAuthorship W3178643921A5027464081 @default.
• W3178643921 hasAuthorship W3178643921A5033768100 @default.
• W3178643921 hasAuthorship W3178643921A5074382097 @default.
• W3178643921 hasAuthorship W3178643921A5076594577 @default.
• W3178643921 hasBestOaLocation W31786439211 @default.
• W3178643921 hasConcept C126322002 @default.
• W3178643921 hasConcept C134018914 @default.
• W3178643921 hasConcept C168563851 @default.
• W3178643921 hasConcept C2777391703 @default.
• W3178643921 hasConcept C2777422806 @default.
• W3178643921 hasConcept C2777451236 @default.
• W3178643921 hasConcept C2778606649 @default.
• W3178643921 hasConcept C2778772119 @default.
• W3178643921 hasConcept C2779134260 @default.
• W3178643921 hasConcept C2779306644 @default.
• W3178643921 hasConcept C2780473172 @default.
• W3178643921 hasConcept C2910068830 @default.
• W3178643921 hasConcept C555293320 @default.
• W3178643921 hasConcept C71924100 @default.
• W3178643921 hasConcept C90924648 @default.
• W3178643921 hasConcept C95190672 @default.
• W3178643921 hasConceptScore W3178643921C126322002 @default.
• W3178643921 hasConceptScore W3178643921C134018914 @default.
• W3178643921 hasConceptScore W3178643921C168563851 @default.
• W3178643921 hasConceptScore W3178643921C2777391703 @default.
• W3178643921 hasConceptScore W3178643921C2777422806 @default.
• W3178643921 hasConceptScore W3178643921C2777451236 @default.
• W3178643921 hasConceptScore W3178643921C2778606649 @default.
• W3178643921 hasConceptScore W3178643921C2778772119 @default.
• W3178643921 hasConceptScore W3178643921C2779134260 @default.
• W3178643921 hasConceptScore W3178643921C2779306644 @default.
• W3178643921 hasConceptScore W3178643921C2780473172 @default.
• W3178643921 hasConceptScore W3178643921C2910068830 @default.

• next